NCT02365935View on ClinicalTrials.gov

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

NACompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

September 30, 2014

Conditions
Uterine Cervical Neoplasms
Interventions
PROCEDURE

Group A adjuvant chemotherapy

In Group A, all patients received 4 cycles of adjuvant chemotherapy every three weeks according to the scheme Cisplatin 100 mg/mq and Paclitaxel 175 mg/mq.

PROCEDURE

Group B adjuvant chemotherapy

In Group B, all patients received 6 cycles of adjuvant chemotherapy every three weeks according to the scheme Cisplatin 100 mg/mq and Paclitaxel 175 mg/mq.

DRUG

Cisplatin

DRUG

Paclitaxel

Trial Locations (1)

00128

campus bio-medico of Rome, Rome

All Listed Sponsors
lead

Campus Bio-Medico University

OTHER

NCT02365935 - 4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery | Biotech Hunter | Biotech Hunter